Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure

David Meier, Daire Grant, Chris Frawley, Mariama Akodad, Uri Landes, Arif A. Kokhar, Dariusz Dudek, Isaac George, Michael J. Rinaldi, Won Keun Kim, Steven J. Yakubov, Paul Sorajja, Giuseppe Tarantini, David A. Wood, John G. Webb, Stephanie L. Sellers, Janarthanan Sathananthan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


BACKGROUND: There are limited data regarding treatment for failed balloon-expandable transcatheter heart valves (THVs) in redo-transcatheter aortic valve implantation (TAVI). AIMS: We aimed to assess THV performance, neoskirt height and expansion when performing redo-TAVI with the ACURATE platform inside a SAPIEN 3 (S3) compared to redo-TAVI with an S3 in an S3. METHODS: Redo-TAVI was performed on the bench using each available size of the S3, the ACURATE neo2 (ACn2) and the next-generation ACURATE Prime XL (AC XL) implanted at 2 different depths within 20 mm/23 mm/26 mm/29 mm S3s serving as the “failed” index THV. Hydrodynamic testing was performed to assess THV function. Multimodality assessment was performed using photography, X-ray, microcomputed tomography (micro-CT), and high-speed videos. RESULTS: The ACURATE in S3 combinations had favourable hydrodynamic performance compared to the S3 in S3 for all size combinations. In the 20 mm S3, redo-TAVI with the ACn2 had lower gradients compared to the S3 (mean gradient 16.3 mmHg for the ACn2 vs 24.7 mmHg for the 20 mm S3 in 20 mm S3). Pinwheeling was less marked for the ACURATE THVs than for the S3s. On micro-CT, the S3s used for redo-TAVI were underexpanded across all sizes. This was also observed for the ACURATE platform, but to a lesser extent. CONCLUSIONS: Redo-TAVI with an ACn2/AC XL within an S3 has favourable hydrodynamic performance and less pinwheeling compared to an S3 in S3. This comes at the price of a taller neoskirt.

Original languageEnglish
Pages (from-to)E376-E388
Issue number6
StatePublished - 2024


  • TAVI
  • preclinical research
  • valve-in-valve


Dive into the research topics of 'Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure'. Together they form a unique fingerprint.

Cite this